Files and links (1)
CC BY V4.0, Open Access
Journal article
Retrotransposition-competent L1s are increased in the genomes of individuals with amyotrophic lateral sclerosis
Experimental biology and medicine (Maywood, N.J.), Vol.250, 10575
2025
Abstract
An individual’s genetics contributes to their risk of developing amyotrophic lateral sclerosis (ALS); however, there is still a large proportion of the heritability of ALS to be understood. Part of this missing heritability may lie in complex variants, such as the long interspersed element 1 (L1) retrotransposon, which have yet to be evaluated. The majority of L1 insertions in the human genome are no longer able to retrotranspose, but to date 279 retrotransposition-competent (RC) L1s have been reported. Many RC-L1s are polymorphic for their presence/absence; therefore, each individual will have a different number and complement of RC-L1s. These elements have been hypothesized to be involved in disease processes by multiple mechanisms such as somatic mutation by retrotransposition, the triggering of neuroinflammation and DNA damage. We hypothesize that L1s may influence disease development either through their effects on endogenous genes or through the properties that enable them to retrotranspose. Whole genome sequencing data from the New York Genome Center ALS consortium were used to characterize L1 variation identifying 2,803 polymorphic L1 elements and association analysis was performed in European individuals (ALS/ALS with other neurological disorder (ALSND) n = 2,653, controls n = 320). There were no individual L1 elements associated with disease, but we did identify a significant increase in the number of RC-L1s in ALS/ALSND genomes (p = 0.01) and the presence of ≥46 RC-L1s showed the most significant association (OR = 1.09 (1.02–1.16), p = 0.01) with disease. Analysis of individual L1s and their association with age at onset and survival identified one L1 whose presence was significantly associated with a lower age at onset (52.7 years) compared to homozygous absent individuals (59.2 years) (padj = 0.009). Our study has identified novel genetic factors for both disease risk and age at onset in ALS providing further evidence for the role of L1 retrotransposons in neurodegenerative diseases.
Details
- Title
- Retrotransposition-competent L1s are increased in the genomes of individuals with amyotrophic lateral sclerosis
- Authors/Creators
- Abigail L. Pfaff - Murdoch University, Personalised Medicine CentreSulev Kõks - Murdoch University
- Publication Details
- Experimental biology and medicine (Maywood, N.J.), Vol.250, 10575
- Publisher
- Frontiers Media S.A.
- Number of pages
- 10
- Identifiers
- 991005787981807891
- Copyright
- © 2025 Pfaff and Kõks.
- Murdoch Affiliation
- Personalised Medicine Centre; Genomics Core Research Facility
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Metrics
60 File views/ downloads
7 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.54 Molecular & Cell Biology - Genetics
- 1.54.1122 Transposable Elements
- Web Of Science research areas
- Medicine, Research & Experimental
- ESI research areas
- Clinical Medicine